Antibiotics-resistant gulls worry scientistsJune 18, 2009The resistance pattern for antibiotics in gulls is the same as in humans, and a new study by Uppsala University researchers shows that nearly half of Mediterranean gulls in southern France have some form of resistance to antibiotics. The study is being published today in the journal PLoS One. Bacteria that develop resistance to antibiotics are one of society's greatest future threats and are having a major impact on our ability to use various medical treatments. The spread of resistance is no longer a local problem in hospitals; antibiotic-resistant bacteria are also spreading to and throughout the environment. The research team at the Uppsala University Department of Medical Pathology has studied the occurrence of antibiotics-resistant bacteria in Mediterranean gulls in southern France. "Gulls have developed behaviors that entail closer and closer contact with us, and opportunities arise for the exchange of bacteria. This is why they are extremely interesting to study," says Mirva Drobni, who directed the study. The findings of the study show that nearly half of the birds carry some form of resistance to antibiotics, and a tenth of them carry ESBL-producing bacteria. These bacteria have the capacity to break down some of our most powerful and important antibiotics and furthermore have an ability to spread extremely rapidly. The researchers were able to show that the resistance pattern was the same among gulls and humans, which indicates that human- and bird-borne bacteria and their resistance mechanisms are being mutually exchanged. "These findings are worrisome as they also indicate a higher degree of resistance in bacteria from gulls than we see in humans in the same region. At present we don't know whether they constitute merely a reservoir for antibiotics resistance or whether they are moreover a source of further dissemination to humans," says Mirva Drobni. Uppsala University |
|||||||||||||||||||||
| Related Antibiotics Current Events and Antibiotics News Articles New study finds MRSA on the rise in hospital outpatients The community-associated strain of the deadly superbug MRSA-an infection-causing bacteria resistant to most common antibiotics-poses a far greater health threat than previously known and is making its way into hospitals, according to a study in the December issue of Emerging Infectious Diseases. A Second Skin Despite advances in treatment regimens and the best efforts of nurses and doctors, about 70% of all people with severe burns die from related infections. Study reveals why certain drug combinations backfire Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow. New imagining technique could lead to better antibiotics and cancer drugs A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist. UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have for the first time successfully reconstituted in the laboratory the enzyme responsible for producing the blockbuster cholesterol-lowering drug lovastatin. Progress made on group B streptococcus vaccine Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. Henry Ford Hospital study: A MRSA strain linked to high death rates A strain of MRSA that causes bloodstream infections is five times more lethal than other strains and has shown to have some resistance to the potent antibiotic drug vancomycin used to treat MRSA, according to a Henry Ford Hospital study. Bacteria 'launch a shield' to resist attack Researchers from the University of Copenhagen and the Technical University of Denmark along with other collaborators in Denmark and the US found that the bacterium Pseudomonas aeruginosa can 'switch on' production of molecules that kill white blood cells - preventing the bacteria being eliminated by the body's immune system. Pumpkin skin may scare away germs The skin of that pumpkin you carve into a Jack-o'-Lantern to scare away ghosts and goblins on Halloween contains a substance that could put a scare into microbes that cause millions of cases of yeast infections in adults and infants each year. Deadly stomach infection rising in community settings, Mayo Clinic study finds Mayo Clinic researchers have found that a sometimes deadly stomach bug, Clostridium difficile is on the rise in outpatient settings. More Antibiotics Current Events and Antibiotics News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||